Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

A Cuadrado, AI Rojo, G Wells, JD Hayes… - Nature reviews Drug …, 2019 - nature.com
The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2) and its
principal negative regulator, the E3 ligase adaptor Kelch-like ECH-associated protein 1 …

Activators and inhibitors of NRF2: a review of their potential for clinical development

N Robledinos-Antón… - Oxidative medicine …, 2019 - Wiley Online Library
The transcription factor NRF2 (nuclear factor erythroid 2‐related factor 2) triggers the first
line of homeostatic responses against a plethora of environmental or endogenous …

[HTML][HTML] The KEAP1-NRF2 pathway: Targets for therapy and role in cancer

S Adinolfi, T Patinen, AJ Deen, S Pitkänen, J Härkönen… - Redox Biology, 2023 - Elsevier
The KEAP1-NRF2 pathway is the key regulator of cellular defense against both extrinsic and
intrinsic oxidative and electrophilic stimuli. Since its discovery in the 1990s, its seminal role …

Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach

A Cuadrado, G Manda, A Hassan, MJ Alcaraz… - Pharmacological …, 2018 - Elsevier
Abstract Systems medicine has a mechanism-based rather than a symptom-or organ-based
approach to disease and identifies therapeutic targets in a nonhypothesis-driven manner. In …

Nrf2, the master regulator of anti-oxidative responses

S Vomund, A Schäfer, MJ Parnham, B Brüne… - International journal of …, 2017 - mdpi.com
Tight regulation of inflammation is very important to guarantee a balanced immune response
without developing chronic inflammation. One of the major mediators of the resolution of …

Modulating NRF2 in disease: timing is everything

M Dodson, MR de la Vega… - Annual review of …, 2019 - annualreviews.org
The transcription factor nuclear factor erythroid 2 (NF-E2)-related factor 2 (NRF2) is a central
regulator of redox, metabolic, and protein homeostasis that intersects with many other …

NRF2 as a regulator of cell metabolism and inflammation in cancer

F He, L Antonucci, M Karin - Carcinogenesis, 2020 - academic.oup.com
Nuclear factor erythroid 2‐related factor 2 (NRF2) is a master transcriptional regulator of
genes whose products defend our cells for toxic and oxidative insults. Although NRF2 …

The KEAP1–NRF2 system as a molecular target of cancer treatment

K Taguchi, M Yamamoto - Cancers, 2020 - mdpi.com
Simple Summary Nuclear factor erythroid-derived 2-like 2 (encoded by the Nfe2l2 gene;
NRF2) is a transcription factor that regulates a variety of cytoprotective genes, including …

Aldo-keto reductases and cancer drug resistance

TM Penning, S Jonnalagadda, PC Trippier… - Pharmacological …, 2021 - Elsevier
Human aldo-keto reductases (AKRs) catalyze the NADPH-dependent reduction of carbonyl
groups to alcohols for conjugation reactions to proceed. They are implicated in resistance to …

[HTML][HTML] AMPK and NRF2: Interactive players in the same team for cellular homeostasis?

E Petsouki, SNS Cabrera, EH Heiss - Free Radical Biology and Medicine, 2022 - Elsevier
NRF2 (Nuclear factor E2 p45‐related factor 2) is a stress responsive transcription factor
lending cells resilience against oxidative, xenobiotic, and also nutrient or proteotoxic insults …